Clinical Trial Update: FMT in Triple Negative Breast Cancer Guided by ctDNA [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is exploring fecal microbiota transplantation for triple-negative breast cancer, guided by ctDNA, in Phase 1/Phase 2, which is currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Jewish General Hospital | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING